September 2021

Avanthi is committed to improve the core competencies and it extends full support to its students, at all times, to meet with the global competitive edge as technical education has immense potentials to generate substantial economic growth in the country. Our students acquire knowledge and relevant skill sets through Classroom Lectures, Case Analysis, Team Work, Academic Projects and Expert Seminars which help develop their Conceptual, Analytical and Decision making Skills.

The National Institute of Immunohaematology is one of the premiere research Institutes of the ICMR, located currently in the premises of the KEM hospital, Parel, Mumbai. The centre, which was started by ICMR to solve problems in blood banking, could successfully initiate research in various other related areas of immunohaematology viz. Population Genetics, Biochemical Genetics, Antenatal Serology, Immunology, HLA and Autoimmune Disorders. Dr.H.M.Bhatia and Dr.A.J.Baxi were the main architects behind this initial programme.

As per Government of India UO No. O.IV-3/2020-Pers.II dated 03/05/2021 & 19/07/2021, CRPF has been declared as Nodal Force for conducting the selection process for filling up the vacancies in Paramedical Cadre in CAPFs & Assam Rifles from the retired CAPF as well as Ex-Armed force personnel for appointment on contractual basis for a period of one year against the vacancies available in Paramedical cadre.

The CSIR-Institute of Himalayan Bioresource Technology, Palampur is one of the National Institutes under the Council of Scientific & Industrial Research which is an autonomous body working under the Department of Scientific and Industrial Research, Ministry of Science & Technology, Government of India. It is spread over 226.1 acres of land with the backdrop of snow-covered peaks of Dhauladhar Range in salubrious climate.

The National Centre for Cell Science is an autonomous institution of Department of Biotechnology, Ministry of Science and Technology, Government of India, for a mandate of basic research, teaching & training, and as a national repository for cell lines/hybridomas etc. The centre is located in the midst of academically enriched environment of University of Savitribai Phule Pune Campus, Pune.

NIPER Ahmedabad was initiated with three specializations Biotechnology, Natural Products and Pharmaceutics and over the period of time three more specialisations Pharmaceutical Analysis, Medicinal Chemistry and Pharmacology and Toxicology were added in 2010. Subsequently in 2011, to cater the needs of Medical device industry in India, another feather was added to the cap of NIPER Ahmedabad in the form of specialisation in Medical Devices.

The tumor suppressor protein p53 is mutated in more than half of all human cancers. Several drugs that potentially can restore mutant p53 to its normal cancer-killing function are in clinical investigation.

However, much remains to be learned about various mutations that lead to a “loss of function” in the protein and others that cause a putative malignant “gain of function,” acceleration of cancerous growth and spread (metastasis), for example.

Vaccinations against human papillomavirus (HPV), a major cause of throat and back of mouth cancers, are expected to yield significant reductions in the rates of these cancers in the U.S., but will not do so until after 2045, according to a new modeling study from researchers at the Johns Hopkins Bloomberg School of Public Health.

The International Vaccine Institute announced the first participant received Bharat Biotech International Ltd’s (BBIL) Chikungunya vaccine candidate (BBV87) in a Phase II/III clinical trial in Costa Rica, marking the start of a multi-country study led by IVI in partnership with BBIL and funded by the Coalition for Epidemic Preparedness Innovations (CEPI) with support from the Ind-CEPI mission of the Department of Biotechnology, India.